BioScrip Cash from Investing Quarterly:
-9.274M for Dec. 31, 2012BioScrip Historical Cash from Investing Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | -9.274M |
| Sept. 30, 2012 | -44.16M |
| June 30, 2012 | 149.06M |
| March 31, 2012 | -1.741M |
| Dec. 31, 2011 | -3.076M |
| Sept. 30, 2011 | -0.962M |
| June 30, 2011 | -3.077M |
| March 31, 2011 | -2.792M |
| Dec. 31, 2010 | -4.103M |
| Sept. 30, 2010 | -7.373M |
| June 30, 2010 | -2.901M |
| March 31, 2010 | -93.91M |
| Dec. 31, 2009 | -1.217M |
| Sept. 30, 2009 | -0.59M |
| June 30, 2009 | -2.855M |
| March 31, 2009 | -1.077M |
| Dec. 31, 2008 | -1.59M |
| Sept. 30, 2008 | -2.171M |
| June 30, 2008 | -1.527M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
| Sept. 30, 2000 | Go Pro |
About Cash From Investing
An item on a company's cash flow statement. Lists aggregate change in cash position resulting from investing activities. Includes the company's cash inflows and outflows from investments in financial markets and the sale of capital assets.
Learn More
BIOS Cash from Investing Quarterly Benchmarks
| Companies | |
|---|---|
| Echo Therapeutics | -0.5019M |
| Alimera Sciences | -0.008M |
| Pacira Pharmaceuticals | 22.36M |
BIOS Cash from Investing Quarterly Rankings
| Overall |
65th percentile 2740 of 8005 |
| Sector |
41st percentile 404 of 686 in Healthcare |
| Industry |
40th percentile 33 of 55 in Drug Manufacturers - Major |
BIOS Cash from Investing Quarterly Range, Past 5 Years
| Minimum | -93.91M | Mar 2010 |
| Maximum | 149.06M | Jun 2012 |
| Average | -1.860M |
